Respiratory Diseases

2025 Activity indicators

  • 1 European project: MORPHEUS (HE)
  • 3 competitive national public projects: ISCIII
  • 2 private projects led
  • 15 clinical studies led
  • 2 competitive HR contracts
  • 58 publications
  • Impact Factor: 375.50
  • Publications in Q1: 32 (55%)
  • Publications in D1: 21 (36%)
  • 1 doctoral thesis supervised and defended
  • 3 awards
  • Reviewers of projects and scientific papers: 1 PI
  • Member of editorial boards: 1 PI

Milestones

  1. Publication in the world's leading cardiology journal: Jiménez D, Dubois-Silva Á, Demelo-Rodríguez P, Ruiz-Artacho P, López-Núñez JJ, Moisés J, Muriel A, Bura-Riviere A, Mahé I, Barillari G, Bikdeli B, Monreal M; RIETE Investigators. Acute pulmonary embolism: a multimarker calculator to predict short-term outcomes. Eur Heart J. Dec. 1, 2025;46(45):4921-4929.
  2. Award for Best Presentation at the Spanish Sleep Society Congress: "Long-term conditioning response following withdrawal of positional therapy in obstructive sleep apnea: a clinical trial."
  3. IRYCIS Young Talent: Dr. Esther Barbero: Awarded her first competitive public research grant under the AES25 call (PI25/00189), "Validation of a simple score to identify the sickest normotensive patients with acute symptomatic pulmonary embolism."
  4. Second national recruiting center in the CASSANDRA study (lung cancer screening in at-risk populations), funded by the Spanish Lung Foundation. SEPARIP: Dr. Rosa Mirambeaux.
  5. International coordination of the clinical trial initiated by ROPE researchers: "Registry-based randomized trial to determine the role of oxygen in acute pulmonary embolism."

Bibliometrics

  Articles Accum. IF Mean IF Articles Q1 or Q2 % in Q1 or Q2 Articles D1 % in D1
2021 51 497.78 9.76 58 114 13 25
2022 50 490.70 9.81 46 92 15 30
2023 37 281.11 7.60 31 84 4 11
2024 54 374.30 6.93 43 80 21 39
2025 58 373,50 8,89 41 71 21 36
  250 2017.39 8.60 204 82 74 28

 *Only original articles, editorials, guidelines and reviews

Networks and alliances